Given that IL-33 was responsible for the enhanced expression of CD25 and CD132 on IL-3–primed basophils in our in-vitro experiments, we next evaluated the expression of IL3 and IL33 in BALF cells from COVID-19 patients. This evidence concerns the gene IL2RA and COVID-19.